These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15535268)

  • 1. [Activity of paclitaxel, epirubicin and carboplatin in patients with advanced or recurrent endometrial cancer].
    Nakashima R; Enomoto T; Murata Y; Fujita M
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():360-4. PubMed ID: 15535268
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy.
    Egawa-Takata T; Ueda Y; Kuragaki C; Miyake T; Miyatake T; Fujita M; Yoshino K; Nakashima R; Okazawa M; Tsutsui T; Morishige K; Kimura T; Yamasaki M; Nishizaki T; Nagamatsu M; Ito K; Asada M; Ogita K; Wakimoto A; Yamamoto T; Nishio Y; Enomoto T
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1603-10. PubMed ID: 21584840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
    Papadimitriou CA; Bafaloukos D; Bozas G; Kalofonos H; Kosmidis P; Aravantinos G; Fountzilas G; Dimopoulos MA;
    Gynecol Oncol; 2008 Jul; 110(1):87-92. PubMed ID: 18455782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
    Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for advanced endometrial cancer with carboplatin and epirubicin.
    Tirmazy SH; Barthakur U; El-Modir A; Anwar S; Fernando I
    Anticancer Res; 2014 Jul; 34(7):3793-8. PubMed ID: 24982404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach.
    Lupe K; Kwon J; D'Souza D; Gawlik C; Stitt L; Whiston F; Nascu P; Wong E; Carey MS
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):110-6. PubMed ID: 17084542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A feasibility study of carboplatin and weekly paclitaxel combination chemotherapy in endometrial cancer: a Kansai Clinical Oncology Group study (KCOG0015 trial).
    Ito K; Tsubamoto H; Itani Y; Kuroboshi H; Fujita H; Nobunaga T; Coleman RL
    Gynecol Oncol; 2011 Feb; 120(2):193-7. PubMed ID: 21075434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced or recurrent endometrial carcinoma.
    Arimoto T; Nakagawa S; Yasugi T; Yoshikawa H; Kawana K; Yano T; Taketani Y
    Gynecol Oncol; 2007 Jan; 104(1):32-5. PubMed ID: 16996113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of cancer chemotherapy on patients with recurrent endometrial carcinoma].
    Kakinoki S; Takizawa K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():365-9. PubMed ID: 15535269
    [No Abstract]   [Full Text] [Related]  

  • 10. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
    Pectasides D; Xiros N; Papaxoinis G; Pectasides E; Sykiotis C; Koumarianou A; Psyrri A; Gaglia A; Kassanos D; Gouveris P; Panayiotidis J; Fountzilas G; Economopoulos T
    Gynecol Oncol; 2008 May; 109(2):250-4. PubMed ID: 18299146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
    Scudder SA; Liu PY; Wilczynski SP; Smith HO; Jiang C; Hallum AV; Smith GB; Hannigan EV; Markman M; Alberts DS;
    Gynecol Oncol; 2005 Mar; 96(3):610-5. PubMed ID: 15721401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with paclitaxel and carboplatin (TC therapy) for endometrial cancer].
    Misawa A; Nagao M; Kushimoto T; Yasuda M
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1901-5. PubMed ID: 19011339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.
    Tinker AV; Bhagat K; Swenerton KD; Hoskins PJ
    Gynecol Oncol; 2005 Jul; 98(1):54-8. PubMed ID: 15904950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer.
    Akram T; Maseelall P; Fanning J
    Am J Obstet Gynecol; 2005 May; 192(5):1365-7. PubMed ID: 15902110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
    Duska LR; Berkowitz R; Matulonis U; Muto M; Goodman A; McIntyre JF; Klein A; Atkinson T; Seiden MV; Campos S
    Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
    Kuoppala T; Mäenpää J; Tomas E; Puistola U; Salmi T; Grenman S; Lehtovirta P; Fors M; Luukkaala T; Sipilä P
    Gynecol Oncol; 2008 Aug; 110(2):190-5. PubMed ID: 18534669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for high-risk early-stage endometrial cancer.
    Kodama J; Seki N; Hiramatsu Y
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):42-7. PubMed ID: 17218851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.
    Sehouli J; Koensgen D; Oskay-Ozcelik G; Mustea A
    Crit Rev Oncol Hematol; 2008 Sep; 67(3):204-12. PubMed ID: 18407513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect.
    Salvinelli F; Casale M; Vincenzi B; Santini D; Di Peco V; Firrisi L; Onori N; Greco F; Tonini G
    J Exp Clin Cancer Res; 2003 Mar; 22(1):155-8. PubMed ID: 12725337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy in metastatic or recurrent endometrial carcinoma].
    Deppe G; Baumann P; Munkarah A
    Zentralbl Gynakol; 2000; 122(7):355-60. PubMed ID: 10951705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.